Seagen Inc

+1.88 (+0.96%)
6:55:12 PM EDT: $196.60 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)37.22B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$560.91 Million
Adjusted EPS-$0.81
See more estimates
10-Day MA$195.28
50-Day MA$199.44
200-Day MA$158.08
See more pivots

Seagen Inc Stock, NASDAQ:SGEN

21823 30th Drive South East, Building 3, Bothell, Washington 98021
United States of America
Phone: +1.425.527.4000
Number of Employees: 3256


Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.